Paid Clinical Trials in Valhalla, NY
As of June 2026, 107 paid clinical trials are recruiting in Valhalla, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Valhalla offers studies at sites including New York Medical College for conditions such as Acute Myeloid Leukemia, ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Valhalla
Trials by drug in Valhalla
Filter results
108 clinical trials
↓ Download CSVHydration & Female Life Stages
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Can Betamethasone Given After Birth Help Extremely Premature Babies Come Off Breathing Support Safely and Effectively?
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Enhancing Heart Allograft Function With the OCS Heart System Trial
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Prospective Multi-center Single Arm Study for Subjects With Chronic Subdural Hematoma Treated With i-ED COILs, Either Alone or in Combination With Burr-holes or Mini-craniotomy
The Effect of Hydration Status on Substrate Oxidation at Rest and During Light and Moderate Exercise
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Combined Aphasia and Robot-Assisted Arm Treatment for Chronic Stroke Survivors
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Effects of Beverage Volume, Glycerol Concentration, and Sodium Concentration on Fluid Balance in Healthy Euhydrated Men and Women at Rest
Effect of Flavored, Carbonated Drinks on Salivary Flow, Salivary Composition, and Taste Perceptions
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
Effect of Adding Glycerol to Electrolyte Beverages on Fluid Balance in Healthy Euhydrated Men and Women at Rest
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
NICU Antibiotics and Outcomes (NANO) Follow-up Study
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
About research studies in Valhalla
Valhalla has approximately 107 recruiting research studies across a wide range of therapeutic areas. New York is home to leading academic medical centers such as Memorial Sloan Kettering, Weill Cornell Medicine, Mount Sinai, NYU Langone, and Columbia University Irving Medical Center. These institutions anchor a research ecosystem that covers oncology, cardiology, neurology, and rare disease.
Top Research Study Locations in Valhalla
Researchers run research studies in Valhalla, NY at 20 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| New York Medical College | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia | 44 |
| Westchester Medical Center | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 37 |
| New York Medical College at Westchester Medical Center | Cystic Fibrosis, Cystic Fibrosis (CF), Cystic Fibrosis Pulmonary Exacerbation | 4 |
| Gatorade Sports Science Institute | Fluid Balance, Hydration Status, Saliva Production | 3 |
| Maria Fareri Children's Hospital | Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Deep Venous Thrombosis | 3 |
| New York Medical Center | Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, B-cell Lymphoma | 2 |
| New York Medical Center/ Maria Fareri Children's Hospital | Refractory and/or Relapsed Metastatic Solid Tumors, Sarcoma, Solid Tumor, Adult | 2 |
| Ambulatory Care Pavilion Westchester Medical Center | End Stage Renal Disease (ESRD) | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Boston Childrens Health Physicians | Juvenile Psoriatic Arthritis | 1 |
| Maria Fareri Children's Hospital (West Chester Medical) | Failed or Difficult Intubation, Sequela, Intubation Complication, Intubation; Difficult | 1 |
| Maria Fareri Children's Hospital at Westchester Medical Center | Bronchopulmonary Dysplasia (BPD), Respiratory Distress Syndrome (RDS) | 1 |
| Maria Farreri Children's Hospital | Pre-term Infants, Respiratory Distress Syndrome | 1 |
| New York Medical College, Maria Fareri Children's Hospital | ADA SCID, Leaky SCID, Omenn Syndrome | 1 |
| Omeros Investigational Site | Hematopoietic Stem Cell Transplantation, Thrombotic Microangiopathies | 1 |
| PepsiCo R&D, Gatorade Sports Science Institute | Fluid Balance | 1 |
| WMCHealth Advanced Physician Services | Obstructive Hypertrophic Cardiomyopathy | 1 |
| Westchester Medical Center / New York Medical College | Aphasia Following Cerebral Infarction, Hemiparesis After Stroke, Stroke | 1 |
| Westchester Medical Center, 100 Woods, Road, Taylor Care Pavillion | Pressure Ulcer, Stage IV, Pressure Ulcers Stage II, Pressure Ulcers Stage III | 1 |
| Westchester Medical College | Acute Myeloid Leukemia, Leukemia | 1 |
Active & Upcoming Studies in Valhalla (2026)
Recruiting trials in Valhalla grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (37 active studies)
- CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma · Phase 1, Phase 2 · New York Medical College
- A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) · Phase 1 · AbbVie
Cardiovascular (9 active studies)
Neurology & pain (3 active studies)
- Combined Aphasia and Robot-Assisted Arm Treatment for Chronic Stroke Survivors · New York Medical College
- Strategy for Improving Stroke Treatment Response · Phase 2 · Translational Sciences, Inc.
Diabetes & metabolic (1 active study)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Common conditions studied in Valhalla
- Acute Myeloid Leukemia (6 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- ARDS (4 active studies). Recruiting ARDS studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- ARDS (Acute Respiratory Distress Syndrome) (4 active studies). Recruiting ARDS (Acute Respiratory Distress Syndrome) studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Acute Respiratory Distress Syndrome (4 active studies). Recruiting Acute Respiratory Distress Syndrome studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Acute Respiratory Distress Syndrome (ARDS) (4 active studies). Recruiting Acute Respiratory Distress Syndrome (ARDS) studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Burkitt Lymphoma (4 active studies). Lymphoma research explores bispecific antibodies, CAR-T cell therapies, and new targeted agents for Hodgkin and non-Hodgkin lymphomas.
Leading research sponsors in Valhalla
- Children's Oncology Group
- New York Medical College
- National Cancer Institute (NCI)
- Merck Sharp & Dohme LLC
- PPD Development, LP
Local regulations and guidelines
Clinical trials in New York are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Trials conducted in New York must also comply with the NY SHIELD Act's data-protection requirements and additional oversight from the New York State Department of Health.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Valhalla. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Valhalla
Hipa.ai aggregates every recruiting study in Valhalla from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Valhalla?
There are approximately 107 recruiting clinical trials in Valhalla, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Valhalla pay participants?
Most recruiting trials in Valhalla compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Valhalla?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Valhalla?
The most common conditions under active study in Valhalla include Acute Myeloid Leukemia (6), ARDS (4), ARDS (Acute Respiratory Distress Syndrome) (4), Acute Respiratory Distress Syndrome (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Valhalla?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Valhalla on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Valhalla?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Valhalla?
Recruiting research sites in Valhalla include New York Medical College, Westchester Medical Center, New York Medical College at Westchester Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Valhalla right now?
The largest active categories in Valhalla are Cancer & tumors (37), Cardiovascular (9), Neurology & pain (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.